AbbVie to Present at the Wolfe Research Healthcare Conference

Rhea-AI Summary

On November 9, 2022, AbbVie (NYSE: ABBV) announced its participation in the 4th Annual Wolfe Research Healthcare Conference scheduled for November 15, 2022, at 10:30 a.m. CT. Key executives, including Rob Michael and Jeffrey Stewart, will present virtually. A live audio webcast will be available on AbbVie's Investor Relations website, with an archived session accessible later that day. AbbVie focuses on innovative medicines in various therapeutic areas, such as immunology, oncology, and neuroscience.

NORTH CHICAGO, Ill., Nov. 9, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 4^th Annual Wolfe Research Healthcare Conference on Tuesday, November 15, 2022. Rob Michael, vice chairman and president, Jeffrey R. Stewart, executive vice president, commercial operations, Scott Reents, senior vice president and chief financial officer, and Neil Gallagher, vice president development and chief medical officer will present virtually at 10:30 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, and women's health, in addition to products and services across our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-wolfe-research-healthcare-conference-301672371.html

SOURCE AbbVie

FAQ

When is AbbVie's presentation at the Wolfe Research Healthcare Conference?

AbbVie's presentation at the Wolfe Research Healthcare Conference is scheduled for November 15, 2022, at 10:30 a.m. Central time.

Who will present for AbbVie at the Wolfe Research Healthcare Conference?

Key executives presenting for AbbVie include Rob Michael, Jeffrey Stewart, Scott Reents, and Neil Gallagher.

How can I access AbbVie's presentation at the conference?

You can access AbbVie's presentation through a live audio webcast on their Investor Relations website at investors.abbvie.com.

Will there be a recording of AbbVie's presentation available?

Yes, an archived edition of AbbVie's presentation will be available later on the same day.

What is AbbVie's focus in terms of therapeutic areas?

AbbVie focuses on innovative medicines in immunology, oncology, neuroscience, eye care, virology, and women's health, among others.